HISTORIC LAUNCH TO LOWER DRUG PRICES FOR AMERICAN PATIENTS: President Donald J. Trump has announced the expansion of TrumpRx.gov, a platform aimed at providing unmatched price transparency and options for generic medications used by millions of Americans daily.
- Starting today, TrumpRx.gov will include over 600 generic medications.
- Americans will have clear and transparent access to the most competitive cash prices for their medications, bypassing insurance middlemen. This will enable them to compare these prices with the co-pays offered by their insurance providers.
- Patients can evaluate the best cash prices available at local pharmacies and through delivery services provided by various private pharmacy programs. Discounts offered by Amazon Pharmacy, Cost Plus Drugs, and GoodRx will be incorporated into TrumpRx.gov.
- These generic medications and their prices will be distinctly listed apart from the discounts on high-cost branded medications negotiated by President Trump through his Most-Favored-Nation drug price agreements.
- Commonly used medications featured on TrumpRx.gov include atorvastatin (cholesterol medication), clopidogrel (blood thinner), lisinopril (high blood pressure medication), and metformin (diabetes medication).
- TrumpRx.gov will showcase many popular everyday medications, excluding controlled substances, drugs with FDA-mandated risk evaluations, and medications not usually available through direct-to-consumer channels.
DRIVING INNOVATION IN TRANSPARENCY AND COMPETITION: This announcement signifies a groundbreaking step in making the drug purchasing process more transparent, competitive, and straightforward for American patients.
- Many patients currently face difficulties paying for their medications and may not know about the numerous discount programs available.
- With this announcement, TrumpRx.gov becomes a central hub where patients can check the best cash price for their medications, allowing insured patients to easily compare these prices with those offered by their insurance companies.
- By listing each company’s discounts in one accessible location, TrumpRx.gov will foster greater cash price competition among the nation’s leading pharmacy discount companies.
DELIVERING ON PROMISES TO PUT AMERICAN PATIENTS FIRST: President Trump is fulfilling his promise to ensure American patients no longer bear high prices to subsidize lower prices in other countries, something previously deemed impossible by the political establishment.
- On May 12, 2025, President Trump signed an Executive Order titled “Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients,” directing the Administration to take steps to align American drug prices with those paid by similar nations.
- On July 31, 2025, President Trump sent letters to 17 leading pharmaceutical companies, detailing the actions they must take to reduce prescription drug prices in the United States to match the lowest prices offered in other developed nations.
- Since September 30, 2025, President Trump has announced 17 agreements with major pharmaceutical manufacturers to align prices with those in other developed nations, providing significant price relief on numerous products used by millions of Americans.
- On December 1, 2025, an agreement was announced by the Office of the United States Trade Representative, the Department of Commerce, and the Department of Health and Human Services with the United Kingdom to increase the net price of new prescription drugs by 25% in the U.K., ensuring they contribute fairly to the cost of innovative medicines.
- On January 15, 2026, President Trump urged Congress to pass The Great Healthcare Plan, which aims to reduce drug prices by formalizing the savings from his Most-Favored-Nation pricing initiative, reduce insurance premiums, hold insurance companies accountable, and enhance price transparency.
- On February 5, 2026, President Trump announced the launch of TrumpRx.gov, a platform allowing cash-paying patients to directly access discounts negotiated by him.
